Fresenius | FRE - Gewinn Vor Steuern

Aktienkurs
41.40
Täglich Wechseln
0.61 1.50%
Monatlich
-7.15%
Jährlich
-0.96%
Q2 Prognose
39.19




Gewinn Vor Steuern Veränderung Datum
Akzo Nobel EUR 148M 598M 2026-03
Alcon AG USD 264M 19M 2025-12
AstraZeneca USD 2.63B 615M 2025-12
BASF EUR 35M 109M 2025-09
Bayer EUR -1.16B 735M 2025-09
Beiersdorf EUR 408.5M 43.5M 2025-06
DaVita Healthcare Partners USD 308.8M 60.13M 2025-09
Demant DKK 1.46B 497M 2025-06
E.ON EUR 173M 522M 2025-09
Essilor EUR 2.45B 1.73B 2025-06
Fresenius EUR 601M 122M 2025-12
Fresenius Medical Care EUR 508.46M 105.89M 2025-12
Getinge SEK 428M 1.54B 2025-03
Givaudan CHF 642M 292M 2024-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
GN Store Nord DKK 450M 332M 2025-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Merck EUR 1.29B 458.1M 2025-09
Novartis USD 4.64B 445M 2025-12
Philips EUR 275M 62M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
RWE EUR 1.08B 189M 2025-09
Sanofi EUR -1.16B 5.5B 2025-12
Smith & Nephew USD 469M 70M 2025-12